RESUMO
BACKGROUND: Robust data on the learning curve (LC) of transcatheter aortic valve replacement (TAVR) are lacking in developing countries. OBJECTIVE: To assess TAVR's LC in Brazil over time. METHODS: We analyzed data from the Brazilian TAVR registry from 2008 to 2023. Patients from each center were numbered chronologically in case sequence numbers (CSNs). LC was performed using restricted cubic splines adjusted for EuroSCORE-II and the use of new-generation prostheses. Also, in-hospital outcomes were compared between groups defined according to the level of experience based on the CSN: 1st to 40th (initial-experience), 41st to 80th (early-experience), 81st to 120th (intermediate-experience), and over 121st (high-experience). Additional analysis was performed grouping hospitals according to the number of cases treated before 2014 (>40 and ≤40 procedures). The level of significance adopted was <0.05. RESULTS: A total of 3,194 patients from 25 centers were included. Mean age and EuroSCORE II were 80.7±8.1 years and 7±7.1, respectively. LC analysis demonstrated a drop in adjusted in-hospital mortality after treating 40 patients. A leveling off of the curve was observed after case #118. In-hospital mortality across the groups was 8.6%, 7.7%, 5.9%, and 3.7% for initial-, early-, intermediate-, and high-experience, respectively (p<0.001). High experience independently predicted lower mortality (OR 0.57, p=0.013 vs. initial experience). Low-volume centers before 2014 showed no significant decrease in the likelihood of death with gained experience, whereas high-volume centers had a continuous improvement after case #10. CONCLUSION: A TAVR LC phenomenon was observed for in-hospital mortality in Brazil. This effect was more pronounced in centers that treated their first 40 cases before 2014 than those that reached this milestone after 2014.
Assuntos
Mortalidade Hospitalar , Curva de Aprendizado , Sistema de Registros , Substituição da Valva Aórtica Transcateter , Humanos , Substituição da Valva Aórtica Transcateter/mortalidade , Substituição da Valva Aórtica Transcateter/estatística & dados numéricos , Brasil/epidemiologia , Feminino , Masculino , Idoso de 80 Anos ou mais , Idoso , Fatores de Tempo , Fatores de Risco , Estenose da Valva Aórtica/cirurgia , Estenose da Valva Aórtica/mortalidade , Resultado do Tratamento , Medição de RiscoRESUMO
One of the most challenging situations in contemporary medicine is, doubtlessly, the approach and treatment of patients presenting with severe left ventricle failure. Since its first clinical application in patients with cardiogenic shock in 1968, the intraaortic balloon pump (IABP) has been widely accepted by heart failure physicians. Although IABP therapy has been shown to be effective for the support and stabilization of hemodynamically compromised patients, it has failed to promote any improvements in patient outcomes. For this reason, much attention has been invested in the development of external devices that can collaborate with the treatment of this condition. In this context, the percutaneous left ventricle assist device (pLVAD), like TandemHeart (Cardiac Assist, Inc.; Pittsburgh, PA, USA), and, more recently, the Impella 2.5 (Abiomed Europe, Aachen, Germany) has emerged. The purpose of this review is to describe the history of pLVAD, from its beginning, to the other devices currently available, including those created for right ventricle and biventricular support.
Assuntos
Insuficiência Cardíaca/cirurgia , Coração Auxiliar/história , Desenho de Equipamento , Coração Auxiliar/efeitos adversos , História do Século XX , História do Século XXI , Humanos , Balão Intra-Aórtico/instrumentaçãoRESUMO
Resumo Fundamento Dados robustos sobre a curva de aprendizagem (LC) da substituição da válvula aórtica transcateter (TAVR) são escassos nos países em desenvolvimento. Objetivo Avaliar a LC da TAVR no Brasil ao longo do tempo. Métodos Analisamos dados do registro brasileiro de TAVR de 2008 a 2023. Pacientes de cada centro foram numerados cronologicamente em número sequencial de caso (NSC). A LC foi realizada usando um spline cúbico restrito ajustado para o EuroSCORE-II e o uso de próteses de nova geração. Ainda, os desfechos hospitalares foram comparados entre grupos definidos de acordo com o nível de experiência, com base no NSC: 1º ao 40º caso (experiência inicial), 41º ao 80º caso (experiência básica), 81º ao 120º caso (experiência intermediária) e 121º caso em diante (experiência alta). Análises adicionais foram conduzidas de acordo com o número de casos tratados antes de 2014 (>40 e ≤40 procedimentos). O nível de significância adotado foi p <0,05. Resultados Foram incluídos 3194 pacientes de 25 centros. A idade média foi 80,7±8,1 anos e o EuroSCORE II médio foi 7±7,1. A análise da LC demonstrou uma queda na mortalidade hospitalar ajustada após o tratamento de 40 pacientes. Um patamar de nivelamento na curva foi observado após o caso 118. A mortalidade hospitalar entre os grupos foi 8,6%, 7,7%, 5,9%, e 3,7% para experiência inicial, básica, intermediária e alta, respectivamente (p<0,001). A experiência alta foi preditora independente de mortalidade mais baixa (OR 0,57, p=0,013 vs. experiência inicial). Centros com baixo volume de casos antes de 2014 não mostraram uma redução significativa na probabilidade de morte com o ganho de experiência, enquanto centros com alto volume de casos antes de 2014 apresentaram uma melhora contínua após o caso de número 10. Conclusão Observou-se um fenômeno de LC para a mortalidade hospitalar do TAVR no Brasil. Esse efeito foi mais pronunciado em centros que trataram seus 40 primeiros casos antes de 2014 que naqueles que o fizeram após 2014.
Abstract Background Robust data on the learning curve (LC) of transcatheter aortic valve replacement (TAVR) are lacking in developing countries. Objective To assess TAVR's LC in Brazil over time. Methods We analyzed data from the Brazilian TAVR registry from 2008 to 2023. Patients from each center were numbered chronologically in case sequence numbers (CSNs). LC was performed using restricted cubic splines adjusted for EuroSCORE-II and the use of new-generation prostheses. Also, in-hospital outcomes were compared between groups defined according to the level of experience based on the CSN: 1st to 40th (initial-experience), 41st to 80th (early-experience), 81st to 120th (intermediate-experience), and over 121st (high-experience). Additional analysis was performed grouping hospitals according to the number of cases treated before 2014 (>40 and ≤40 procedures). The level of significance adopted was <0.05. Results A total of 3,194 patients from 25 centers were included. Mean age and EuroSCORE II were 80.7±8.1 years and 7±7.1, respectively. LC analysis demonstrated a drop in adjusted in-hospital mortality after treating 40 patients. A leveling off of the curve was observed after case #118. In-hospital mortality across the groups was 8.6%, 7.7%, 5.9%, and 3.7% for initial-, early-, intermediate-, and high-experience, respectively (p<0.001). High experience independently predicted lower mortality (OR 0.57, p=0.013 vs. initial experience). Low-volume centers before 2014 showed no significant decrease in the likelihood of death with gained experience, whereas high-volume centers had a continuous improvement after case #10. Conclusion A TAVR LC phenomenon was observed for in-hospital mortality in Brazil. This effect was more pronounced in centers that treated their first 40 cases before 2014 than those that reached this milestone after 2014.
RESUMO
A 38-year-old man with acute myocardial infarction in the lower wall affecting the right ventricle underwent thrombolytic treatment with streptokinase. Approximately 2 hours after the thrombolytic treatment started, he presented with signs of coronary reocclusion. He underwent emergency cineangiocoronariography that revealed that his right coronary artery was completely occluded by a clot. He unsuccessfully underwent angioplasty and stent implantation. After the concomitant use of glycoprotein IIb/IIIa inhibitor, coronary TIMI III flow was achieved without additional dilations, and he was discharged from the hospital 5 days later with no further complications.
Assuntos
Angioplastia Coronária com Balão/métodos , Fibrinolíticos/uso terapêutico , Infarto do Miocárdio/terapia , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/antagonistas & inibidores , Estreptoquinase/uso terapêutico , Adulto , Angioplastia Coronária com Balão/efeitos adversos , Angiografia Coronária/métodos , Quimioterapia Combinada , Humanos , Masculino , Infarto do Miocárdio/diagnóstico por imagem , Infarto do Miocárdio/tratamento farmacológico , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/uso terapêuticoRESUMO
OBJECTIVE: To assess the safety and efficacy of unsupervised rehabilitation (USR) in the long run in low-risk patients with coronary artery disease. METHODS: We carried out a retrospective study with 30 patients divided into: group I (GI) - 15 patients from private clinics undergoing unsupervised rehabilitation; group II (GII) - control group, 15 patients from ambulatory clinic basis, paired by age, sex, and clinical findings. GI was stimulated to exercise under indirect supervision (jogging, treadmill, and sports). GII received the usual clinical treatment. RESULTS: The pre- and postobservation values in GI were, respectively: VO2 peak (mL/kg/min), 24+/-5 and 31+/- 9; VO2 peak/peak HR: 0.18+/-0.05 and 0.28+/-0.13; peak double product (DP peak):26,800+/-7,000 and 29,000 +/- 6,500; % peak HR/predicted HRmax: 89.5+/-9 and 89.3+/-9. The pre- and post- values in GII were: VO2 peak (mL/kg/min), 27+/- 7 and 28+/-5; VO2 peak/peak HR: 0.2+/-0.06 and 0.2+/- 0.05; DP peak: 24,900+/-8,000 and 25,600+/- 8,000, and % peak HR/predicted HRmax: 91.3+/-9 and 91.1+/- 11. The following values were significant: preobservation VO2 peak versus postobservation VO2 peak in GI (p=0.0 063); postobservation VO2 peak in GI versus postobservation VO2 peak in GII (p=0.0045); postobservation VO2 peak/peak HR GI versus postobservation peak VO2/peak HR in GII (p=0.0000). The follow-up periods in GI and GII were, respectively, 41.33+/- 20.19 months and 20.60+/-8.16 months (p<0.05). No difference between the groups was observed in coronary risk factors, therapeutic management, or evolution of ischemia. No cardiovascular events secondary to USR were observed in 620 patient-months. CONCLUSION: USR was safe and efficient, in low-risk patients with coronary artery disease and provided benefits at the peripheral level.
Assuntos
Doença das Coronárias/reabilitação , Terapia por Exercício , Cooperação do Paciente , Limiar Anaeróbio , Estudos de Casos e Controles , Teste de Esforço , Tolerância ao Exercício , Feminino , Seguimentos , Frequência Cardíaca , Humanos , Masculino , Pessoa de Meia-Idade , Consumo de Oxigênio/fisiologia , Pico do Fluxo Expiratório/fisiologiaRESUMO
INTRODUCTION: Left ventricular hypertrophy (LVH) is an independent predictor of cardiovascular risk in patients with chronic renal disease (CRD) on hemodialysis (HD). OBJECTIVE: To show the usefulness of chest radiography in the diagnosis of LVH in CRD patients on HD. METHODS: Cross-sectional study including 100 patients (58 men and 42 women), mean age 46.2 ± 14.0 years, with CRD of all causes, for at least six months on HD. Were obtained echocardiogram and chest x-rays of patients, always up to one hour after the end of HD sessions. RESULTS: LVH was detected in 83 patients (83%), of whom 56 (67.4%) had the concentric pattern and 27 (32.6%) with eccentric pattern of LVH. Cardiomegaly - defined by cardiothoracic index (CTI) > 0.5 - was present in 61 patients (61%). The following were the sensitivity, specificity and accuracy, respectively, for the variable ICT: 66.2%, 70.5% and 68.0%. The Pearson correlation between ICT and index of left ventricular mass (LVMI) was 0.552 (p < 0.05) and positive likelihood ratio of 2.2. CONCLUSION: Chest radiography is a safe and useful as a diagnostic tool of LVH in CKD patients on HD.
Assuntos
Hipertrofia Ventricular Esquerda/etiologia , Insuficiência Renal Crônica/complicações , Adolescente , Adulto , Idoso , Estudos Transversais , Feminino , Humanos , Hipertrofia Ventricular Esquerda/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Radiografia Torácica , Diálise Renal , Insuficiência Renal Crônica/terapia , Ultrassonografia , Adulto JovemRESUMO
BACKGROUND: Serum cystatin C (s-CC), an endogenous marker of kidney function, has also been proposed as a cardiovascular risk marker. However, it is unknown whether it is a direct marker of atherosclerosis, independently of kidney function. OBJECTIVE: The aim of this study was to correlate s-CC with two surrogate markers of subclinical atherosclerosis. METHODS: This is a cross-sectional study involving 103 middle-aged (57.49 ± 11.7 years) hypertensive outpatients, being 60 female (58.25%), most with preserved kidney function. S-CC was correlated with carotid intima media thickness (IMT) and flow-mediated dilation of brachial artery (FMD), both assessed by ultrasound, as well as with measured creatinine clearance and established cardiovascular risk factors. RESULTS: S-CC was neither significantly correlated with IMT (r = -0.024; p = 0.84) nor with FMD (r = -0.050 and p = 0.687) and no significant association was observed with conventional risk factors and inflammatory markers. In univariate analysis, s-CC was correlated with measured creatinine clearance (r = -0,498; p < 0,001), age (r = 0,408; p < 0,001), microalbuminuria (r = 0,291; p = 0,014), uric acid (r = 0,391; p < 0,001), ratio E/e' (r = 0,242; p = 0,049) and Framingham score (r = 0,359; p = 0,001). However, after multiple regression analysis, only the association with measured creatinine clearance remained significant (r = -0,491; p < 0,001). CONCLUSION: In middle-aged hypertensive outpatients, s-CC correlated with measured creatinine clearance, as expected, but no association was observed with markers of atherosclerosis neither with established cardiovascular risk factors.
Assuntos
Aterosclerose/sangue , Cistatina C/sangue , Hipertensão/sangue , Fatores Etários , Idoso , Aterosclerose/diagnóstico , Biomarcadores/sangue , Artéria Braquial/fisiopatologia , Espessura Intima-Media Carotídea , Creatinina/sangue , Estudos Transversais , Feminino , Humanos , Hipertensão/fisiopatologia , Rim/fisiopatologia , Masculino , Pessoa de Meia-Idade , Fatores de RiscoRESUMO
A meta-analysis of clinical studies of patients with cardiovascular disease demonstrated that the use of aspirin was associated with a 22% decrease in death rates and relevant ischemic vascular events. However, clinical studies demonstrated that patients that regularly took aspirin presented recurrence of cardiovascular events. Such observation led to the question whether, in some patients, the aspirin was not effective in blocking platelet aggregation and these patients were called unresponsive to aspirin or aspirin-resistant. The clinical aspirin resistance is characterized as the occurrence of cardiovascular events in patients during treatment with aspirin, whereas the laboratory resistance is defined as the persistence of platelet aggregation, documented by laboratory test, in patients regularly taking aspirin. Patients that are aspirin-resistant presented, according to laboratory tests, on average 3.8 times more cardiovascular events when compared to non-resistant ones.
Assuntos
Aspirina/farmacologia , Resistência a Medicamentos , Inibidores da Agregação Plaquetária/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Doenças Cardiovasculares/induzido quimicamente , Doenças Cardiovasculares/epidemiologia , Humanos , RecidivaRESUMO
O implante de valva aórtica transcateter (TAVI) é uma alternativa para pacientes com estenose aórtica de alto risco cirúrgico e para muitos daqueles considerados inoperáveis. Apesar de sua característica minimamente invasiva, podem ocorrer complicações relacionadas ao procedimento. Obstrução coronária durante o TAVI é uma complicação rara, com incidência inferior a 1%, mas potencialmente letal. Em nosso país, essa complicação foi encontrada em 0,72% dos procedimentos − 3 de 418 casos do Registro Brasileiro de Implante de Bioprótese Aórtica por Cateter − com mortalidade hospitalar de 100%. Apresentamos, neste relato de caso, medidas de prevenção e tratamento de oclusão coronária após o TAVI.
Transcatheter aortic valve implantation (TAVI) is an alternative for patients with aortic stenosis at high surgical risk and for many of those considered inoperable. Despite its minimally invasive features,complications related to the procedure may occur. Coronary obstruction during TAVI is a rare (incidence rate of less than 1%) but potentially lethal complication. In Brazil, this complication was found in 0.72% of procedures three of 418 cases from the Brazilian Transcatheter Aortic Valve Implantation Registry with an in-hospital mortality rate of 100%. This case report presents prevention and treatment measures forcoronary occlusion after TAVI.
Assuntos
Humanos , Feminino , Idoso , Estenose da Valva Aórtica/terapia , Implante de Prótese de Valva Cardíaca/métodos , Oclusão Coronária/complicações , Oclusão Coronária/terapia , Angioplastia/métodos , Artéria Femoral , Catéteres , Ecocardiografia/métodos , Fatores de Risco , Intervenção Coronária Percutânea/métodos , Stents , Valva Aórtica/cirurgiaRESUMO
BACKGROUND: In patients with type 1 diabetes mellitus, atherosclerosis occurs earlier in life and coronary artery disease (CAD) constitutes the major cause of death. OBJECTIVE: Evaluate the prevalence and anatomic characteristics of coronary artery disease (CAD) in type 1 diabetic patients with chronic renal failure undergoing hemodialysis. METHODS: This is a descriptive study of 20 patients with type 1 diabetes mellitus undergoing hemodialysis without known CAD. CAD was assessed by quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS). QCA was performed in all lesions >30%, visually. All proximal 18-mm segments of the coronary arteries were analyzed by IVUS. All other coronary segments with stenosis >30% were also analyzed. RESULTS: Angiography detected 29 lesions >30% in 15 patients (75%). Eleven (55%) of the lesions were >50% and 10 (50%) >70%. Thirteen patients had all 3 major arteries interrogated by IVUS. Atherosclerosis was present in all patients and in all 51 proximal 18-mm segments analyzed. The mean vessel diameter of these segments was significantly larger at the IVUS than at the QCA, for all vessels. IVUS images of 25 (86.2%) of the 29 lesions >30% were obtained. Fibrotic plaques were common (48%) and 60% had intermediate vessel remodeling. CONCLUSION: CAD was present in all vessels of all type 1 diabetic patients undergoing hemodialysis. These findings are in agreement with other autopsy, angiography and IVUS studies. Additionally, they indicate the need for additional epidemiological and imaging studies to better understand and treat such a complex and serious clinical condition affecting young people.
Assuntos
Doença da Artéria Coronariana/patologia , Vasos Coronários/patologia , Diabetes Mellitus Tipo 1/complicações , Angiopatias Diabéticas/patologia , Falência Renal Crônica/terapia , Diálise Renal , Adulto , Angiografia Coronária , Doença da Artéria Coronariana/diagnóstico por imagem , Vasos Coronários/diagnóstico por imagem , Angiopatias Diabéticas/diagnóstico por imagem , Feminino , Humanos , Masculino , Estudos Prospectivos , Fatores de Tempo , UltrassonografiaRESUMO
BACKGROUND: Left ventricular hypertrophy (LVH) is an independent predictor of cardiovascular risk, and its characterization and prevalence in chronic renal disease (CRD) should be further studied. OBJECTIVE: To establish the diagnosis of LVH in patients with stage-5 CRD using six different electrocardiographic criteria, and to correlate them with left ventricular mass index (LVMI) as obtained by echocardiography. METHODS: Cross-sectional study including 100 patients (58 men and 42 women, mean age 46.2 + or - 14.0 years) with CRD of all causes undergoing hemodialysis (HD) for at least six months. Electrocardiography (ECG) and echocardiography were performed in all patients, always up to one hour after the end of the HD sessions. RESULTS: LVH was detected in 83 patients (83%), of whom 56 (67.4%) had the concentric pattern and 27 (32.6%) the eccentric pattern of LVH. Diagnostic sensitivity, specificity and accuracy of all the electrocardiographic methods studied were higher than 50%. Using Pearson's linear correlation for LVMI, only the Sokolow-Lyon voltage criterion did not show a > or = 0.50 coefficient. Calculation of the likelihood ratio, in turn, showed that ECG has a discriminatory power for the diagnosis of LVH in the population studied, with emphasis on the Cornell-product and Romhilt-Estes criteria. No correlation was observed between LVMI and QTc and QTc dispersion. CONCLUSION: ECG is a useful, efficient, and highly reproducible method for the diagnosis of LVH in HD patients. In this population, the Cornell-product proved to be the most reliable criterion for the detection of LVH.
Assuntos
Eletrocardiografia/métodos , Hipertrofia Ventricular Esquerda/diagnóstico , Falência Renal Crônica/complicações , Adulto , Idoso , Eletrocardiografia/normas , Métodos Epidemiológicos , Feminino , Ventrículos do Coração/diagnóstico por imagem , Humanos , Hipertrofia Ventricular Esquerda/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Ultrassonografia , Adulto JovemRESUMO
Introdução: A hipertrofia ventricular esquerda (HVE) é um fator preditor independente de risco cardiovascular em pacientes com doença renal crônica (DRC) em hemodiálise (HD). Objetivo: Mostrar a utilidade da radiografia de tórax no diagnóstico de HVE em pacientes com DRC em HD. Métodos: Estudo transversal que incluiu 100 pacientes (58 homens e 42 mulheres), idade média de 46,2 ± 14,0 anos, com DRC de todas as etiologias, há pelo menos seis meses em HD. Foram obtidos ecocardiograma e radiografia de tórax dos pacientes, sempre até uma hora após o término das sessões de HD. Resultados: A HVE foi detectada em 83 pacientes (83%), dos quais 56 (67,4%) apresentavam o padrão concêntrico e 27 (32,6%) a padrão excêntrico de HVE. Cardiomegalia - definida por índice cardiotorácico (ICT) > 0,5 - esteve presente em 61 pacientes (61%). Foram os seguintes os valores de sensibilidade, especificidade e acurácia, respectivamente, para a variável ICT: 66,2%, 70,5% e 68,0%. A correlação de Pearson entre ICT e índice de massa do ventrículo esquerdo (IMVE) foi de 0,552 (p < 0,05) e razão de verossimilhança positivo de 2,2. Conclusão: A radiografia de tórax é um exame seguro e útil como ferramenta diagnóstica de HVE em pacientes com DRC em HD. .
Introduction: Left ventricular hypertrophy (LVH) is an independent predictor of cardiovascular risk in patients with chronic renal disease (CRD) on hemodialysis (HD). Objective: To show the usefulness of chest radiography in the diagnosis of LVH in CRD patients on HD. Methods: Cross-sectional study including 100 patients (58 men and 42 women), mean age 46.2 ± 14.0 years, with CRD of all causes, for at least six months on HD. Were obtained echocardiogram and chest x-rays of patients, always up to one hour after the end of HD sessions. Results: LVH was detected in 83 patients (83%), of whom 56 (67.4%) had the concentric pattern and 27 (32.6%) with eccentric pattern of LVH. Cardiomegaly - defined by cardiothoracic index (CTI) > 0.5 - was present in 61 patients (61%). The following were the sensitivity, specificity and accuracy, respectively, for the variable ICT: 66.2%, 70.5% and 68.0%. The Pearson correlation between ICT and index of left ventricular mass (LVMI) was 0.552 (p < 0.05) and positive likelihood ratio of 2.2. Conclusion: Chest radiography is a safe and useful as a diagnostic tool of LVH in CKD patients on HD. .
Assuntos
Adolescente , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Hipertrofia Ventricular Esquerda/etiologia , Insuficiência Renal Crônica/complicações , Estudos Transversais , Hipertrofia Ventricular Esquerda , Hipertrofia Ventricular Esquerda , Radiografia Torácica , Diálise Renal , Insuficiência Renal Crônica/terapiaRESUMO
BACKGROUND: Predischarge exercise testing early after myocardial infarction is useful for risk stratification, exercise prescription, and assessment of prognosis and treatment. OBJECTIVE: The objective of this study was to compare the findings of exercise testing early after myocardial infarction with those of echocardiography, electrocardiographic monitoring (24-hour Holter monitoring) and coronary angiography. METHODS: We evaluated 60 cases (mean age of 51.42 +/- 9.34 years), of which 46 were males (77%). The symptom-limited maximal exercise test according to the Naughton protocol12 was performed between the sixth day of hospitalization and hospital discharge, with the patients on medication. During hospitalization, the patients underwent echocardiography, electrocardiographic monitoring and coronary angiography. The significance level was set at 0.05 (alpha = 5%). RESULTS: Exercise testing had a poor performance in the detection of multivessel coronary artery disease (sensitivity, 42%; specificity, 69%). No significant differences were found when the presence of ischemia on exercise test was compared with multivessel coronary disease, complex ventricular arrhythmias on electrocardiographic monitoring, and the finding of an ejection fraction lower than 60% on echocardiography (p = 0.56), as well as with the presence of multivessel lesions, complex ventricular arrhythmias on electrocardiographic monitoring and abnormal ejection fraction on echocardiography (p = 0.36). CONCLUSION: The presence of ischemia during exercise testing was associated with the occurrence of ventricular arrhythmias on electrocardiographic monitoring, with reduced ejection fraction on echocardiography, as well as with the presence of multivessel coronary lesions, which constitutes an indicator of a high coronary risk.
Assuntos
Teste de Esforço , Infarto do Miocárdio/fisiopatologia , Doença da Artéria Coronariana/diagnóstico , Estudos Transversais , Ecocardiografia , Eletrocardiografia Ambulatorial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/diagnóstico por imagem , Prognóstico , Estudos Prospectivos , RadiografiaRESUMO
Fundamentos: Tanto a hipertrofia ventricular esquerda (HVE) como a disfunção endotelial representam importantes fatores de risco cardiovascular. No entanto, a correlação entre HVE e disfunção endotelial tem sido pouco explorada e ainda é motivo de controvérsias. Objetivo: Investigar a correlação entre o índice de massa do ventrículo esquerdo (IMVE) e a dilatação mediada por fluxo de artéria braquial (DMF), adotada como estimativa da função endotelial, em indivíduos hipertensos. Materiais e Métodos: Trata-se de estudo transversal envolvendo 94 hipertensos sem doença cardiovascular manifesta, com média de idade de 56,99 ± 11,89 anos, sendo 68,1% do sexo feminino. Todos os participantes foram submetidos a exame clínico, pesquisa de fatores de risco cardiovascular, dosagens bioquímicas, ecodopplercardiografia para determinação do IMVE e pesquisa da DMF por ultra-sonografia de alta resolução. Utilizouse a regressão linear múltipla para pesquisa da associação entre IMVE e DMF. Resultados: A média do IMVE foi de 104,4 ± 26,2 g/m2 e a da DMF, de 5,2 ± 5,7%. Na análise de regressão linear simples, observou-se uma correlação inversa significativa entre o IMVE e a DMF (ß = -0,389, p = 0,007). Após análise de regressão multivariada, a associação persistiu independentemente da pressão arterial, tanto sistólica quanto diastólica, proteína C reativa ultrassensível (PCR-US) e de outros fatores de risco cardiovascular. Conclusão: Observou-se correlação inversa significativa entre IMVE e DMF em hipertensos sem doença cardiovascular manifesta, independentemente da pressão arterial e do status inflamatório.
Background: Both left ventricular hypertrophy (LVH) and endothelial dysfunction represent important cardiovascular risk factors. However, the correlation between LVH and endothelial dysfunction has been little explored and is still a matter of controversies. Objective: To investigate the correlation between left ventricular mass index (LVMI) and flow-mediated dilation (FMD) of brachial artery , used as an estimative measure of endothelial dysfunction, in hypertensive patients. Materials and Methods: This is a cross-sectional study involving 94 middle-aged (56,99 ± 11,89 years) hypertensive outpatients without overt cardiovascular disease, being 68,1% female. All the participants underwent clinical examination, biochemical analyses, search for cardiovascular risk factors, transthoracic echocardiography for the determination of LVMI and assessment of FMD using a high-resolution Doppler B-mode ultrasound equipment. A multiple linear regression model was used to analyse the association between LVMI and DMF. Results: Mean LVMI was 104,4 ± 26,2 g/m2 and mean DMF, 5,2 ± 5,7%. Using simple linear regression, it was observed a significant inverse correlation between LVMI and FMD (ß = -0,389, p =0,007). This association remained significant even after adjustment for systolic and diastolic blood pressure, high sensitivity C-reactive protein (hs-CRP) and many other cardiovascular risk factors. Conclusions: In these hypertensive patients without overt cardiovascular disease, it was observed a significant inverse correlation between LVMI and FMD, which was independent of blood pressure and inflammatory status.
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Endotélio , Ventrículos do Coração , Hipertensão , Hipertrofia Ventricular Esquerda , VasodilataçãoRESUMO
BACKGROUND: Drug-eluting stents represent an additional option to treat coronary artery disease. This technology represents a major breakthrough that may require additional funding in the short-term to enable its inclusion in procedures of the Unified Health System. OBJECTIVE: To estimate the impact on the Unified Health System budget in the first year of use of drug-eluting stents. METHODS: A Budget Impact Model was designed to predict the economic impact of the inclusion of drug-eluting stents in the Unified Health System budget. Data about costs and local procedures were collected in multiple sources, specifically procedure volume data, hospital costs, cost of stents, drug costs and number of stents used in single and multi-vessel procedures. RESULTS: The results in the first year indicate that the impact on the Unified Health System is of 12.8% in the best scenario and 24.4% in the worst scenario, representing an increase by R$ 24 to 44 million in the total projected budget. CONCLUSION: Drug-eluting stents have an additional cost compared with standard stents in the first year of use in the Unified Health System.
Assuntos
Stents Farmacológicos/economia , Custos de Cuidados de Saúde , Brasil , Análise Custo-Benefício , Humanos , Modelos EconômicosRESUMO
Relatamos nossa experiência inicial com o GuideLinerTM, uma extensão de cateter-guia de rápida troca tipo child, desenvolvido para facilitar a entrega de stents e balões em intervençõesarteriais percutâneas complexas. Descrevemos sua utilização em um caso com lesão coronária complexa, em outro com anatomia complexa, e em um terceiro caso com dissecção do enxerto de artéria torácica interna esquerda. Todos os procedimentos foram realizados com sucesso. O GuideLinerTMpode auxiliar no tratamento de lesões arteriais complexas e de complicações durante o procedimento.
Assuntos
Humanos , Masculino , Idoso , Angioplastia/métodos , Angioplastia , Doença da Artéria Coronariana/diagnóstico , Revascularização Miocárdica/métodos , Revascularização Miocárdica , Catéteres , Estenose Coronária/complicações , Estenose Coronária/diagnósticoRESUMO
OBJECTIVE: To evaluate the feasibility, safety and accuracy of dobutamine/atropine stress echocardiography (DASE) for the detection of coronary artery disease (CAD) in renal transplant candidates. METHODS: Patients candidates to renal transplant were submitted consecutively to DASE and coronary angiography. The adopted angiographic criteria for CAD were an obstructive lesion of > or = 50% and > or = 70%. RESULTS: 148 patients underwent the DASE and the coronary angiography. Mean age was 52 +/- 9 years, 69% of the patients were males; 27% had diabetic nephropathy and 73% had LVH; 63% were asymptomatic; 36% and 22% presented coronary obstructions > or = 50% and 70%, respectively. The DASE performance was 91% and major complication rate was 2.7%. The sensibility, specificity and accuracy for the diagnosis of coronary obstruction > 50% were 53% (CI:45-61), 87% (CI:81-93), and 75% (CI:63-83) respectively. For coronary obstruction > or = 70% these values were, respectively, 71% (CI:64-92), 85% (CI:79-91) and 81% (CI:75-87). The sensibility to detect univessel and multivessel disease was 41% (CI:19-63) and 78% (CI:64-92), respectively. CONCLUSION: The DASE was practical and safe; however, it presented a poor result for the detection of CAD regarding obstructions > or = 50%. It can be a useful screening for the detection of CAD in candidates with obstructions > or = 70% and multivessel disease.
Assuntos
Atropina , Doença das Coronárias/diagnóstico por imagem , Dobutamina , Ecocardiografia sob Estresse , Falência Renal Crônica/complicações , Transplante de Rim , Adulto , Idoso , Cardiotônicos , Doença das Coronárias/complicações , Estudos de Viabilidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
FUNDAMENTO: A cistatina C sérica (s-CC), um marcador endógeno da função renal, tem sido proposta também como um marcador de risco cardiovascular. No entanto, ainda não está estabelecido se se trata de um marcador direto de aterosclerose, independentemente da função renal. OBJETIVO: O objetivo deste estudo foi correlacionar a s-CC com dois marcadores substitutos de aterosclerose subclínica. MÉTODOS: Trata-se de um estudo transversal envolvendo 103 pacientes hipertensos ambulatoriais, de meia idade (57,49 ± 11,7 anos), sendo 60 do sexo feminino (58,25%) e a maioria com função renal preservada. A s-CC foi correlacionada com a espessura mediointimal carotídea (EMIc) e a dilatação mediada por fluxo de artéria braquial (DMF), ambas avaliadas por ultrassonografia, bem como com o clearance de creatinina medido e fatores de risco cardiovascular estabelecidos. RESULTADOS: A s-CC não se correlacionou significativamente nem com a EMIc (r = -0,024, p = 0,84) nem com a DMF (r = -0,050 e p = 0,687), e não foi observada também associação significativa com fatores de risco convencionais nem marcadores inflamatórios. Na análise univariada, a s-CC se correlacionou com o clearance de creatinina medido (r = - 0,498, p < 0,001), idade (r = 0,408, p < 0,001), microalbuminúria (r = 0,291, p = 0,014), ácido úrico (r = 0,391, p < 0,001), relação E/e' (r = 0,242, p = 0,049) e escore de Framingham (r = 0,359, p = 0,001). No entanto, após análise de regressão múltipla, apenas a associação com o clearance de creatinina medido permaneceu significativa (r = -0,491, p <0,001). CONCLUSÃO: Em pacientes hipertensos ambulatoriais de meia idade, a s-CC se correlacionou com o clearance de creatinina medido,como esperado, mas não foi observada associação com marcadores de aterosclerose nem com fatores de risco cardiovascular estabelecidos.
BACKGROUND: Serum cystatin C (s-CC), an endogenous marker of kidney function, has also been proposed as a cardiovascular risk marker. However, it is unknown whether it is a direct marker of atherosclerosis, independently of kidney function. OBJECTIVE: The aim of this study was to correlate s-CC with two surrogate markers of subclinical atherosclerosis. METHODS: This is a cross-sectional study involving 103 middle-aged (57.49 ± 11.7 years) hypertensive outpatients, being 60 female (58.25%), most with preserved kidney function. S-CC was correlated with carotid intima media thickness (IMT) and flow-mediated dilation of brachial artery (FMD), both assessed by ultrasound, as well as with measured creatinine clearance and established cardiovascular risk factors. RESULTS: S-CC was neither significantly correlated with IMT (r = -0.024; p = 0.84) nor with FMD (r = -0.050 and p = 0.687) and no significant association was observed with conventional risk factors and inflammatory markers. In univariate analysis, s-CC was correlated with measured creatinine clearance (r = -0,498; p < 0,001), age (r = 0,408; p < 0,001), microalbuminuria (r = 0,291; p = 0,014), uric acid (r = 0,391; p < 0,001), ratio E/e' (r = 0,242; p = 0,049) and Framingham score (r = 0,359; p = 0,001). However, after multiple regression analysis, only the association with measured creatinine clearance remained significant (r = -0,491; p < 0,001). CONCLUSION: In middle-aged hypertensive outpatients, s-CC correlated with measured creatinine clearance, as expected, but no association was observed with markers of atherosclerosis neither with established cardiovascular risk factors.
Assuntos
Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Aterosclerose/sangue , Cistatina C/sangue , Hipertensão/sangue , Fatores Etários , Aterosclerose/diagnóstico , Biomarcadores/sangue , Artéria Braquial/fisiopatologia , Espessura Intima-Media Carotídea , Estudos Transversais , Creatinina/sangue , Hipertensão/fisiopatologia , Rim/fisiopatologia , Fatores de RiscoRESUMO
Paciente do sexo feminino, de 36 anos de idade e sem fatores de risco para doença cardiovascular, foi atendida com quadro clínico de angina do peito. O eletrocardiograma demonstrava inversão de onda T em D2, D3 e aVF. A cineangiocoronariografia demonstrou imagem sugestiva de dissecção coronária espontânea no terço proximal de artéria coronária direita, comprometendo gravemente a luz e o fluxo arteriais. Avaliação adicional foi realizada com ultrassom intracoronário, que orientou o planejamento da intervenção coronária percutânea subsequente com stent e analisou o resultado final após o implante. A dissecção coronária espontânea é causa rara de síndrome coronária aguda e afeta principalmente mulheres jovens no período gestacional. Pouco se sabe sobre sua fisiopatologia. O prognóstico e o tratamento dependem da extensão da dissecção e da artéria comprometida.
A 36-year-old female, with no cardiovascular risk factors, was examined with angina pectoris. Electrocardiogram showed T wave inversion in D2, D3 and aVF surface leads. The patient was submitted to coronary angiography that showedan image suggestive of spontaneous coronary dissection on the proximal segment of the right coronary artery, severely compromising arterial lumen and flow. Additional evaluation included intravascular ultrasound, which guided the subsequent percutaneous coronary intervention with stent implantation and assessed the final result. Spontaneous coronary dissection is a rare cause of acute coronary syndrome and affects mainly young women in the gestational age. Little is known about its pathophysiology. Prognosis and treatment depend on the length of dissection and the compromised artery.
Assuntos
Humanos , Feminino , Adulto Jovem , Angina Pectoris/diagnóstico , Angina Pectoris , Síndrome Coronariana Aguda , Angiografia Coronária , DissecaçãoRESUMO
Introdução: A estenose da artéria do rim transplantado (EART) é a principal complicação vascular associada a eventos adversos em pacientes portadores de enxerto renal, cuja incidência varia de 1% a 23%. A arteriografia é o padrão de referência para o diagnóstico, possibilitando tratamento imediato; porém, em decorrência da anatomia variável e da localização da anastomose, muitas vezes são necessárias projeções adicionais, levando a maior exposição ao contraste e à radiação. A angiografia rotacional com reconstrução tridimensional (tridimensional rotational angiography 3D-RA) surge como ferramenta para o diagnóstico e o tratamento da EART. O objetivo deste estudo foi avaliar a acurácia das medidas obtidas pela 3D-RA, comparativamente à obtida pela angiografia convencional. Métodos: De abril de 2010 a janeiro de 2011, foram realizadas 41 3D-RA em pacientes com alta suspeita clínica de EART. As imagens foram analisadas por observadores independentes, sendo as medidas da arteriografia convencional obtidas no momento do procedimento e as da 3D-RA, após o processamento das imagens pelo software Philips Allure 3D-RA. Resultados: Foram analisadas 35 3D-RA (84%) consideradas adequadas para a realização das medidas angiográficas, das quais 20% contribuíram com informações adicionais relevantes para a estratégia terapêutica. Não houve diferença estatisticamente significante entre as medidas dos diâmetros de referência e luminal mínimo da artéria obtidas pela 3D-RA e pela angiografia convencional, além de ter havido forte correlação entre elas. Conclusões: A 3D-RA surge como ferramenta útil para o diagnóstico da EART, encaao obter medidas acuradas, oferecer informações complementares e relevantes para o diagnóstico e tratamento, além de potencialmente reduzir o tempo do procedimento e a exposição ao contraste e à radiação.
Background: Transplant renal artery stenosis (TRAS) is the major vascular complication associated to adverse events in patients with kidney grafts, whose incidence ranges from1% to 23%. Angiography is the gold-standard for diagnosis, enabling immediate treatment; however, due to the variable anatomy and location of anastomosis, additional projectionsare often required, leading to greater exposure to contrast medium and radiation. Tridimensional rotational angiography (3D-RA) appears as a tool for diagnosis and treatment of TRAS. The aim of this paper was to evaluate the accuracy of measurements obtained by 3D-RA in comparison to conventionalangiography. Methods: From April, 2010 to January, 2011, 41 3D-RAs were performed in patients with clinicalsuspicion of TRAS. Images were analyzed by independent observers; conventional angiography measurements were obtained online and 3D-RA measurements were obtained offline with the Philips Allure 3D-RA software. Results: Thirty-five3D-RAs (84%) were considered adequate for angiographic measurements, and 20% provided additional and relevant information for the therapeutic strategy. There was no statistically significant difference between measurements obtainedfrom the reference diameter and minimal luminal diameter of the artery using 3D-RA and conventional angiography. In addition, there was a strong correlation between them.Conclusions: 3D-RA comes up as a useful tool for TRAS diagnosis, providing accurate measurements and complementary and relevant information for the diagnosis and treatment, in addition to potentially reducing procedure time and exposure to contrast and radiation.